These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16442710)

  • 1. Interleukin-6 level in patients with colorectal cancer.
    Esfandi F; Mohammadzadeh Ghobadloo S; Basati G
    Cancer Lett; 2006 Nov; 244(1):76-8. PubMed ID: 16442710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of tissue expression of interleukin-6 in colorectal carcinoma.
    Chung YC; Chaen YL; Hsu CP
    Anticancer Res; 2006; 26(5B):3905-11. PubMed ID: 17094421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer.
    Sørensen NM; Schrohl AS; Jensen V; Christensen IJ; Nielsen HJ; Brünner N
    Scand J Gastroenterol; 2008; 43(2):186-91. PubMed ID: 18224564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The levels of selected cytokines in patients with colorectal cancer--a preliminary report].
    Grotowski M; Piechota W
    Pol Merkur Lekarski; 2001 Oct; 11(64):327-9. PubMed ID: 11770312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative interleukin-6 production by mononuclear blood cells predicts survival after radical surgery for colorectal carcinoma.
    Clinchy B; Fransson A; Druvefors B; Hellsten A; Håkansson A; Gustafsson B; Sjödahl R; Håkansson L
    Cancer; 2007 May; 109(9):1742-9. PubMed ID: 17345614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of interleukin-17 in human colorectal cancer.
    Wägsäter D; Löfgren S; Hugander A; Dimberg J
    Anticancer Res; 2006; 26(6B):4213-6. PubMed ID: 17201135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
    Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
    Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human neutrophil peptides 1, 2 and 3 are biochemical markers for metastatic colorectal cancer.
    Albrethsen J; Møller CH; Olsen J; Raskov H; Gammeltoft S
    Eur J Cancer; 2006 Nov; 42(17):3057-64. PubMed ID: 17015013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
    Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
    Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
    Hsia CY; Huo TI; Chiang SY; Lu MF; Sun CL; Wu JC; Lee PC; Chi CW; Lui WY; Lee SD
    Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Receptors of selected cytokines and angiokine bFGF in patients with colorectal cancer (a preliminary study)].
    Grotowski M; Piechota W
    Pol Merkur Lekarski; 2001 Nov; 11(65):398-401. PubMed ID: 11852807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage.
    Sebzda T; Saleh Y; Gburek J; Warwas M; Andrzejak R; Siewinski M; Rudnicki J
    J Exp Ther Oncol; 2006; 5(3):223-9. PubMed ID: 16528972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
    Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
    Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tissue inhibitor of metalloproteinase-1 (TIMP-1) in colorectal cancer: correlation with clinico-morphological factors].
    Korotkova EA; Gershteĭn ES; Prorokov VV; Kushlinskiĭ NE
    Vopr Onkol; 2009; 55(2):171-6. PubMed ID: 19514370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
    Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
    Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A dynamic observation on serum cytokine and immunoglobulin (IgG, IgA, IgM) in patients with esophageal cancer].
    Tang RG; Yuan XH; Tang TT; Tang XQ; Hang YQ; Qin HJ; Chen HM; Fang WZ; Long XK
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jun; 41 Suppl():35-8. PubMed ID: 17767855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
    Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL;
    J Clin Oncol; 2006 Sep; 24(26):4301-8. PubMed ID: 16896001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant p53 protein in the serum of patients with colorectal cancer: Correlation with the level of carcinoembryonic antigen and serum epidermal growth factor receptor.
    Abdel-Aziz MM; Lotfy M; El-Kady IM; Abozaid M
    Cancer Detect Prev; 2009; 32(4):329-35. PubMed ID: 16632243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum level and genotype of interleukin-6 in patients with esophageal cancer].
    Tang RG; Wei YS; Chen HM; Fang WZ; Long XK; Yuan XH
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(16):1126-8. PubMed ID: 17672997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.
    Yoo PS; Sullivan CA; Kiang S; Gao W; Uchio EM; Chung GG; Cha CH
    Ann Surg Oncol; 2009 Jan; 16(1):200-7. PubMed ID: 19009247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.